Effects of thyroid hormone on the cardiovascular system

Recent Progress in Hormone Research

Volumn 59, Issue , 2004, Pages 31-50

  Fazio, Serafino ^a   Palmieri, Emiliano A ^a   Lombardi, Gaetano ^a   Biondi, Bernadette ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

3,5 DIIODOTHYROPROPIONIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; LEVOTHYROXINE; THYROID HORMONE; THYROID HORMONE DERIVATIVE; UNCLASSIFIED DRUG;

ATHEROSCLEROSIS; BETA ADRENERGIC RECEPTOR BLOCKING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CARDIOVASCULAR SYSTEM; DISEASE ASSOCIATION; HEART ATRIUM ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE MASS; HEART MUSCLE CONTRACTILITY; HEART RATE; HEART SURGERY; HIGH OUTPUT HEART FAILURE; HORMONE METABOLISM; HORMONE RELEASE; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; MORTALITY; PREVALENCE; REVIEW; SUPRAVENTRICULAR TACHYCARDIA; VASCULAR RESISTANCE; PATHOPHYSIOLOGY; PHYSIOLOGY; THYROID GLAND;

CARDIOVASCULAR DISEASES; CARDIOVASCULAR SYSTEM; HUMANS; HYPERTHYROIDISM; HYPOTHYROIDISM; THYROID GLAND; THYROID HORMONES;

EID: 2342429953     PISSN: 00799963     EISSN: None     Source Type: Journal    
DOI: 10.1210/rp.59.1.31     Document Type: Review

References (115)

1. Aber CP 1964 The heart in hypothyroidism. Am Heart J 68:428-430
2. Andersen S, Pedersen KM, Brunn NH, et al. 2002 Narrow individual variations in serum T4 and T3 in normal subjects: a clue to understanding of subclinical thyroid disease. J Clin Endocrinol Metab 87:1068-1072
3. Anthonisen P, Holst E, Thomson AA 1960 Determination of cardiac output and other hemodynamic data in patients with hyper- and hypothyroidism, using dye dilution technique. Scand J Clin Lab Invest 12:472-480
4. Auer J, Scheibner P, Mische T, et al. 2001 Subclinical hyperthyroidism as a risk factor for atrial fibrillation. Am Heart J 142:838-842
5. Bengel FM, Nekolla SG, Ibrahim T, et al. 2000 Effect of thyroid hormones on cardiac function, geometry, and oxidative metabolism assessed noninvasively by positron emission tomography and magnetic resonance imaging. J Clin Endocrinol Metab 85:1822-1827
6. Bettendorf M, Schmidt KG, Tiefenbacher U, et al. 1997 Transient secondary hypothyroidism in children after cardiac surgery. Pediatr Res 41:375-379
7. Bettendorf M, Schmidt KG, Grulich-Henn J, et al. 2000 Tri-iodothyronine treatment in children after cardiac surgery: a double-blind, randomized, placebo-controlled study. Lancet 356:529-534
8. Bindels AJ, Westendorp RG, Frolich M, et al. 1999 The prevalence of subclinical hypothyroidism at different total plasma cholesterol levels in middle aged men and women: a need for case-finding? Clin Endocrinol 50:217-220
9. Biondi B, Fazio S, Carella C, et al. 1993 Cardiac effects of long-term thyrotropin-suppressive therapy with levothyroxine. J Clin Endocrinol Metab 77:334-337
10. Biondi B, Fazio S, Carella C, et al. 1994 Control of adrenergic overactivity by B-blockade improves quality of life in patients receiving long term suppressive therapy with levothyroxine. J Clin Endocrinol Metab 78:1028-1033
11. Biondi B, Fazio S, Cuocolo A, et al. 1996 Impaired cardiac reserve and exercise capacity in patients receiving long-term thyrotropin suppressive therapy with levothyroxine. J Clin Endocrinol Metab 81:4224-4228
12. Biondi B, Fazio S, Palmieri EA, et al. 1999a Left ventricular diastolic dysfunction in patients with subclinical hypothyroidism. J Clin Endocrinol Metab 84:2064-2067
13. Biondi B, Fazio S, Palmieri EA, et al. 1999b Effects of chronic subclinical hyperthyroidism on cardiac morphology and function. Cardiologia 44:443-449
14. Biondi B, Palmieri EA, Fazio S, et al. 2000 Endogenous subclinical hyperthyroidism affects quality of life and cardiac morphology and function in young and middle-aged patients. J Clin Endocrinol Metab 85:4702-4705
15. Biondi B, Palmieri EA, Lombardi G, et al. 2002a Effects of thyroid hormone on cardiac function: the relative importance of heart rate, loading conditions, and myocardial contractility in the regulation of cardiac performance in human hyperthyroidism. J Clin Endocrinol Metab 87:968-974
16. Biondi B, Fazio S, Palmieri EA, et al. 2002b Mortality in elderly patients with subclinical hyperthyroidism. Lancet 359:799-800
17. Biondi B, Palmieri EA, Lombardi G, et al. 2002c Effects of subclinical thyroid dysfunction on the heart. Ann Intern Med 137:904-914
18. Brent GA 1994 The molecular basis of thyroid hormone action. N Engl J Med 331:847-853
19. Brenta G, Mutti LA, Schnitman M, et al. 2003 Assessment of left ventricular diastolic function by radionuclide ventriculography at rest and exercise in subclinical hypothyroidism, and its response to L-thyroxine therapy. Am J Cardiol 2003 91:1327-1330
20. Cacciatori V, Bellavere F, Pezzarossa A, et al. 1996 Power spectral analysis of heart rate in hyperthyroidism. J Clin Endocrinol Metab 81:2828-2835
21. Canaris GJ, Manowitz NR, Mayor G, et al. 2000 The Colorado thyroid disease prevalence study. Arch Intern Med 160:526-534
22. Ching GW, Franklyn JA, Stallard TJ, et al. 1996 Cardiac hypertrophy as a result of long-term thyroxine therapy and thyrotoxicosis. Heart 75:363-368
23. Chu JW, Crapo LM 2001 The treatment of subclinical hypothyroidism is seldom necessary. J Clin Endocrinol Metab 86:4591-4599
24. Cimochowski GE, Harostock MD, Foldes PG 1997 Minimal operative mortality in patients undergoing coronary artery bypass with significant left ventricular dysfunction by maximization of metabolic and mechanical support. J Thorac Cardiovasc Surg 113:655-666
25. Crowley WF Jr, Ridgway EC, Bough EW, et al. 1977 Noninvasive evaluation of cardiac function in hypothyroidism. Response to gradual thyroxine replacement. N Engl J Med 296:1-6
26. Danese MD, Ladenson PW, Meinert CL, et al. 2000 Effect of thyroxine therapy on serum lipoproteins in patients with mild thyroid failure: a quantitative review of the literature. J Clin Endocrinol Metab 85:2993-3001
27. Davis PJ, Davis FB 1993 Acute cellular actions of thyroid hormone and myocardial function. Ann Thorac Surg 56(suppl):S16-S23
28. DeGroot WJ, Leonard JJ 1970 Hyperthyroidism as a high cardiac output state. Am Heart J 79:265-275
29. Dernellis J, Panaretou M 2002 Effects of thyroid replacement therapy on arterial blood pressure in patients with hypertension and hypothyroidism. Am Heart J 143:718-724
30. Di Bello V, Monzani F, Giorgi D, et al. 2002 Ultrasonic myocardial textural analysis in subclinical hypothyroidism. J Am Soc Echocardiogr 13:832-840
31. Dillmann WH 1990 Biochemical basis of thyroid hormone action in the heart. Am J Med 88:626-630
32. Duntas LH 2002 Thyroid disease and lipids. Thyroid 12:287-293
33. Duntas LH, Mantzou E, Koutras DA 2002 Circulating levels of oxidized low-density lipoprotein in overt and mild hypothyroidism. Thyroid 12:1003-1007
34. Endo T, Komiya I, Tsukui T, et al. 1979 Re-evaluation of a possible high incidence of hypertension in hypothyroid patients. Am Heart J 98:684-688
35. Everts ME, Verhoeven FA, Bezstarosti K, et al. 1996 Uptake of thyroid hormone in neonatal rat cardiac myocytes. Endocrinology 137:4235-4242
36. Faber J, Petersen L, Wiinberg N, et al. 2002 Hemodynamic changes after levothyroxine treatment in subclinical hypothyroidism. Thyroid 12:319-324
37. Fazio S, Biondi B, Carella C, et al. 1995 Diastolic dysfunction in patients on thyroid-stimulating-hormone suppressive therapy with levothyroxine: beneficial effect of β blockade. J Clin Endocrinol Metab 80:2222-2226
38. Feldman T, Borow KM, Same DH, et al. 1986 Myocardial mechanics in hyperthyroidism: importance of left ventricular loading conditions, heart rate and contractile state. J Am Coll Cardiol 7:967-974
39. Fletcher AK, Weetman AP 1998 Hypertension and hypothyroidism. J Hum Hypertens 12:79-82
40. Foldes J, Istvanfy M, Halmagyi H, et al. 1987 Hypothyroidism and the heart. Examination of left ventricular function in subclinical hypothyroidism. Acta Med Hung 44:337-347
41. Fommei E, Iervasi G 2002 The role of thyroid hormone in blood pressure homeostasis: evidence from short-term hypothyroidism in humans. J Clin Endocrinol Metab 87:1996-2000
42. Franklyn JA, Gammage MD, Ramsden DB, et al. 1984 Thyroid status in patients after acute myocardial infarction. Clin Sci (Lond) 67:585-590
43. Fredlund BO, Olsson SB 1983 Long QT interval and ventricular tachycardia of "torsade de pointe" type in hypothyroidism. Acta Med Scand 213:231-235
44. Friedman MJ, Okada RD, Ewy GA, et al. 1982 Left ventricular systolic and diastolic function in hyperthyroidism. Am Heart J 104:1303-1308
45. Gibson JG, Harris AW 1939 Clinical studies on the blood volume: V. Hyperthyroidism and myxedema. J Clin Invest 18:59-65
46. Gick GG, Melikian J, Ismail-Beigi F 1990 Thyroidal enhancement of rat myocardial Na,K-ATPase: preferential expression of alpha 2 activity and mRNA abundance. J Membr Biol 115:273-282
47. Gilligan DM, Ellenbogen KA, Epstein AE 1996 The management of atrial fibrillation. Am J Med 101:413-421
48. Graettinger JS, Muenster JJ, Selverstone LA, et al. 1959 A correlation of clinical and hemodynamic studies in patients with hyperthyroidism with and without congestive heart failure. J Clin Invest 39:1316-1327
49. Greenland P, Daviglus ML, Dyer AR, et al. 1999 Resting heart rate is a risk factor for cardiovascular and noncardiovascular mortality: the Chicago Heart Association Detection Project in Industry. Am J Epidemiol 149:853-862
50. Haider AW, Larson MG, Benjamin EJ, et al. I998 Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death. J Am Coll Cardiol 32:1454-1459
51. Hak AE, Pols HAP, Visser TJ, et al. 2000 Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Ann Intern Med 132:270-278
52. Hamilton MA, Stevenson LW, Luu M, et al. 1990 Altered thyroid hormone metabolism in advanced heart failure. J Am Coll Cardiol 16:91-95
53. Hamilton MA, Stevenson LW, Fonarow GC, et al. 1998 Safety and hemodynamic effects of intravenous triiodothyronine in advanced congestive heart failure. Am J Cardiol 81:443-447
54. Hoit BD, Khoury SF, Shao Y, et al. 1997 Effects of thyroid hormone on cardiac beta-adrenergic responsiveness in conscious baboons. Circulation 96:592-598
55. Holland FW II, Brown PS Jr, Weintraub BD, et al. 1991 Cardiopulmonary bypass and thyroid function: a "euthyroid sick syndrome." Ann Thorac Surg 52:46-50
56. Huber G, Staub JJ, Meier C, et al. 2002 Prospective study of the spontaneous course of subclinical hypothyroidism: prognostic value of thyrotropin, thyroid reserve, and thyroid antibodies. J Clin Endocrinol Metab 87:3221-3226
57. Kahaly GJ 2000 Cardiovascular and atherogenic aspects of subclinical hypothyroidism. Thyroid 10:665-679
58. Kahaly GJ, Nieswandt J, Wagner S, et al. 1998 Ineffective cardiorespiratory function in hyperthyroidism. J Clin Endocrinol Metab 83:4075-4078
59. Kahaly GJ, Wagner S, Nieswandt J, et al. 1999 Stress echocardiography in hyperthyroidism. J Clin Endocrinol Metab 84:2308-2313
60. Katzeff HL, Powell SR, Ojamaa K 1997 Alteration in cardiac contractility and gene expression during low-T3 syndrome: prevention with T3. Am J Physiol 273:E951-E956
61. Keating FR, Parkin TW, Selby JB, et al. 1960 Treatment of heart disease associated with myxedema. Prog Cardiovasc Dis 3:364-381
62. Kinugawa K, Minobe WA, Wood WM, et al. 2001 Signaling pathways responsible for fetal gene induction in the failing human heart: evidence for altered thyroid hormone receptor gene expression. Circulation 103:1089-1094
63. Kiss E, Jakab G, Kranias EG, et al. 1994 Thyroid hormone induced alteration in phospholamban protein expression: regulatory effects on sarcoplasmic reticulum Ca2+ transport and myocardial relaxation. Circ Res 75:245-251
64. Kiss E, Brittsan AG, Elds I, et al. 1998 Thyroid hormone-induced alterations in phospholamban-deficient mouse hearts. Circ Res 83:608-613
65. Klein I 1988 Thyroxine-induced cardiac hypertrophy: time course of development and inhibition by propanolol. Endocrinology 123:203-210
66. Klein I 1989 Thyroid hormone and high blood pressure. In: Laragh JH, Brenner BM, Kaplan NM, eds. Endocrine Mechanisms in Hypertension, vol. 2. New York: Raven Press; 61-80
67. Klein I, Levey GS 1984 Unusual manifestations of hypothyroidism. Arch Intern Med 144:123-128
68. Klein I, Ojamaa K 1998 Thyroid hormone treatment of congestive heart failure. Am J Cardiol 81:490-491
69. Klein I, Ojamaa K 2000 The cardiovascular system in hypothyroidism. In: Braverman LE, Utiger RD, eds. Werner & Ingbar's The Thyroid: A Fundamental and Clinical Text, edit. 8. Philadelphia: Lippincott Williams & Wilkins; 777-782
70. Klein I, Ojamaa K 2001 Thyroid hormone and the cardiovascular system. N Engl J Med 344:501-509
71. Klemperer JD, Klein I, Gomez M, et al. 1995 Thyroid hormone treatment after coronary-artery bypass surgery. N Engl J Med 333:1522-1527
72. Ladenson PW 1993 Thyrotoxicosis and heart: something old and something new. J Clin Endocrinol Metab 77:332-333
73. Ladenson PW, Sherman SI, Boughman RL, et al. 1992 Reversible alterations in myocardial gene expression in a young man with dilated cardiomyopathy and hypothyroidism. Proc Natl Acad Sci USA 89:5251-5255
74. Lekakis J, Papamichael C, Alevizaki M, et al. 1997 Flow-mediated, endothelium-dependent vasodilatation is impaired in subjects with hypothyroidism, borderline hypothyroidism, and high-normal serum thyrotropin (TSH) values. Thyroid 7:411-414
75. Levey GS, Klein I 1990 Catecholamine-thyroid hormone interactions and the cardiovascular manifestations of hyperthyroidism. Am J Med 88:642-646
76. Lewis BS, Ehrenfeld EN, Lewis N, et al. 1979 Echocardiographic LV function in thyrotoxicosts. Am Heart J 97:460-468
77. Luboshitzky R, Aviv A, Herer P, et al. 2002 Risk factors for cardiovascular disease in women with subclinical hypothyroidism. Thyroid 12:421-425
78. Magner J, Clark W, Allenby P 1988 Congestive heart failure and sudden death in a young woman with thyrotoxicosis. West J Med 110:759-760
79. McAllister RM, Delp MD, Loughlin MH 1995 Thyroid status and exercise tolerance. Cardiovascular and metabolic consideration. Sport Med 20:189-198
80. McDermott MT, Ridgway EC 2001 Subclinical hypothyroidism is mild thyroid failure and should be treated. J Clin Endocrinol Metab 86:4585-4590
81. McDermott MM, Feinglass J, Sy J, et al. 1995 Hospitalized congestive heart failure patients with preserved versus abnormal left ventricular systolic function: clinical characteristics and drug therapy. Am J Med 99:629-635
82. Mercuro G, Panzuto MG, Bina A, et al. 2000 Cardiac function, physical exercise capacity, and quality of life during long-term thyrotropin-suppressive therapy with levothyroxine: effect of individual dose tailoring. J Clin Endocrinol Metab 85:159-164
83. Merillon JP, Passa P, Chastre J, et al. 1981 Left ventricular function and hyperthyroidism. Br Heart J 46:137-143
84. Mintz G, Pizzarello R, Klein I 1991 Enhanced left ventricular diastolic function in hyperthyroidism: noninvasive assessment and response to treatment. J Clin Endocrinol Metab 73:146-150
85. Monzani F, Di Bello V, Caraccio N, et al. 2001 Effects of levo-thyroxine on cardiac function and structure.in subclinical hypothyroidism: a double blind, placebo-controlled study. J Clin Endocrinol Metab 86:1110-1115
86. Morkin E 1993 Regulation of myosin heavy chain genes in the heart. Circulation 87:1451-1460
87. Morkin E, Pennock GD, Spooner PH, et al. 2002 Clinical and experimental studies on the use of 3,5-diiodothyropropionic acid, a thyroid hormone analogue, in heart failure. Thyroid 12:527-533
88. Moruzzi P, Doria E, Agostoni PG 1996 Medium-term effectiveness of L-thyroxine treatment in idiopathic dilated cardiomyopathy. Am J Med 101:461-467
89. Müller B, Tsakiris DA, Roth CB, et al. 2001 Haemostatic profile in hypothyroidism as potential risk factor for vascular or thrombotic disease. Eur J Clin Invest 31:131-137
90. Mullis-Janson SL, Argenziano M, Corwin S, et al. 1999 A randomized double-blind study of the effect of triiodothyronine on cardiac function and morbidity after coronary bypass surgery. J Thorac Cardiovasc Surg 117:1128-1134
91. Nakazawa HK, Sakurai K, Humada N, et al. 1982 Management of atrial fibrillation in the post-thyrotoxic state. Am J Med 72:903-906
92. Napoli R, Biondi B, Guardasole V, et al. 2001 Impact of hyperthyroidism and its correction on vascular reactivity in humans. Circulation 104:3076-3080
93. Nordyke RA, Gilbert FI Jr, Harada AS 1988 Graves' disease. Influence of age on clinical findings. Arch Intern Med 148:626-631
94. Obuobie K, Smith J, Evans LM, et al. 2002 Increased central arterial stiffness in hypothyroidism. J Clin Endocrinol Metab 87:4662-4666
95. Ojamaa K, Klemperer JD, Klein I 1996a Acute effects of thyroid hormone on vascular smooth muscle. Thyroid 6:505-512
96. Ojamaa K, Klemperer JD, MacGilvray SS, et al. 1996b Thyroid hormone and hemodynamic regulation of beta-myosin heavy chain promoter in the heart. Endocrinology 137:802-808
97. Ojamaa K, Sabet A, Kenessey A, Shenoy R, et al. 1999 Regulation of rat cardiac Kv1.5 gene expression by thyroid hormone is rapid and chamber specific. Endocrinology 140:3170-3176
98. Ojamaa K, Klein I, Sabet A, Steinberg SF 2000 Changes in adenylyl cyclase isoforms as a mechanism for thyroid hormone modulation of cardiac beta-adrenergic receptor responsiveness. Metabolism 49:275-279
99. Ojamaa K, Kenessey A, Klein I 2002 Thyroid hormone regulation of phospholamban phosphorylation in the rat heart. Endocrinology 141:2139-2144
100. Park KW, Dai HB, Ojamaa K, et al. 1997 The direct vasomotor effect of thyroid hormones on rat skeletal muscle resistance arteries. Anesth Analg 85:734-738
101. Parle JV, Maisonneuve P, Sheppard MC, et al. 2001 Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study. Lancet 358:861-865
102. Petersen P, Hansen JM 1988 Stroke in thyrotoxicosis with atrial fibrillation. Stroke 19:15-18
103. Resnick LM, Laragh JH 1982 Plasma renin activity in syndromes of thyroid hormone excess and deficiency. Life Sci 30:585-586
104. Saito I, Ito K, Saruta T 1983 Hypothyroidism as a cause of hypertension. Hypertension 5:112-115
105. Sawin CT, Geller A, Wolf PA, et al. 1994 Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med 331:1249-1252
106. Shapiro LE, Sievert R, Ong L, et al. 1997 Minimal cardiac effects in asymptomatic athyreotic patients chronically treated with thyrotropin- suppressive doses of L-thyroxine. J Clin Endocrinol Metab 82:2592-2595
107. Streeten DH, Anderson GH Jr, Howland T, et al. 1988 Effects of thyroid function on blood pressure. Recognition of hypothyroid hypertension. Hypertension 11:78-83
108. Sun ZQ, Ojamaa K, Nakamura TY, et al. 2001 Thyroid hormone increases pacemaker activity in rat neonatal atrial myocytes. J Mol Cell Cardiol 33:811-824
109. Theilen EO, Wilson WR 1967 Hemodynamic effects of peripheral vasoconstriction in normal and thyrotoxic subjects. J Appl Physiol 22:207-210
110. Tunbridge WMG, Evered DC, Hall R, et al 1977 The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol (Oxf) 7:481-493
111. Vanderpump MP, Tunbridge WM, French JM, et al. 1995 The incidence of thyroid disease in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol 43:55-69
112. Vitale G, Galderisi M, Lupoli GA, et al. 2002 Left ventricular myocardial impairment in subclinical hypothyroidism assessed by a new ultrasound tool: pulsed tissue Doppler. J Clin Endocrinol Metab 87:4350-4355
113. von Olshausen K, BischolT S, Kahaly G, et al. 1989 Cardiac arrhythmias and heart rate in hyperthyroidism. Am J Cardiol 63:930-933
114. Walker JD, Crawford FA, Kalo S, et al. 1994 The novel effects of 3,5,3′-triiodo-L-thyronine on myocyte contractile function and beta-adrenergic responsiveness in dilated cardiomyopathy. J Thorac Cardiovasc Surg 108:672-679
115. Wieshammer S, Keck FS, Waitzinger J, et al. 1989 Acute hypothyroidism slows the rate of left ventricular diastolic relaxation. Can J Physiol Pharmacol 67:1007-1010